An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
2022 · Signal Transduction and Targeted Therapy · 55 citations
https://doi.org/10.1038/s41392-022-00912-4
L
Lan Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.8K
Citations
24
h-index
40
i10-index
Lan Chen is an academic researcher from Juravinski Cancer Centre. The author has contributed to research in topics: Immunotherapy and Immune Responses & SARS-CoV-2 and COVID-19 Research & CAR-T cell therapy research. The author has an h-index of 24, co-authored 68 publications.
ORCID: 0000-0003-1481-8535Papers by this author
worksRegulation of Alveolar Epithelial Na+ Channels by ERK1/2 in Chlorine-Breathing Mice
2011 · American Journal of Respiratory Cell and Molecular Biology · 47 citations
https://doi.org/10.1165/rcmb.2011-0309oc
Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs
2025 · Nature Immunology · 27 citations
https://doi.org/10.1038/s41590-024-02072-9
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants
2018 · Cell Reports · 25 citations
https://doi.org/10.1016/j.celrep.2018.06.040
Impact of AhR, CYP1A1 and GSTM1 Genetic Polymorphisms on TP53 R273G Mutations in Individuals Exposed to Polycyclic Aromatic Hydrocarbons
2014 · Asian Pacific Journal of Cancer Prevention · 24 citations
https://doi.org/10.7314/apjcp.2014.15.6.2699
Profiling of viral load, antibody and inflammatory response of people with monkeypox during hospitalization: a prospective longitudinal cohort study in China
2024 · EBioMedicine · 17 citations
https://doi.org/10.1016/j.ebiom.2024.105254
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat